SYMPLICITY HTN-3 trial shows no significant effect of renal denervation on systolic blood pressure

被引：0
|
作者：
机构：
来源：
Nature Reviews Nephrology | 2014年 / 10卷 / 6期
关键词：
D O I：
10.1038/nrneph.2014.72
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：299 / 299
相关论文
共 50 条
  • [31] SYMPLICITY HTN-3 trial: what is it and what does it mean?
    Boehm, Michael
    Mahfoud, Felix
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (26) : 1697 - 1698
  • [32] Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials
    Kjeldsen, Sverre E.
    Narkiewicz, Krzysztof
    Oparil, Suzanne
    Hedner, Thomas
    [J]. BLOOD PRESSURE, 2014, 23 (03) : 135 - 137
  • [33] FAILURE OF RENAL DENERVATION IN SYMPLICITY HTN-3 IS A PREDICTABLE RESULT OF ANATOMICALLY INADEQUATE OPERATIVE TECHNIQUE AND NOT THE TRUE LIMITATIONS OF THE TECHNOLOGY
    Pekarskiy, S.
    Baev, A.
    Mordovin, V.
    Sitkova, E.
    Semke, G.
    Ripp, T.
    Falkovskaya, A.
    Krylov, A.
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 : E108 - E108
  • [34] Opinion of the German Society of Cardiology on the Symplicity HTN-3 Study in Patients with resistant Arterial Hypertension after Renal Denervation
    Boehm, M.
    Hamm, C. W.
    Kuck, K. -H.
    Ertl, G.
    Mahfoud, F.
    Schunkert, H.
    [J]. KARDIOLOGE, 2014, 8 (03): : 244 - 245
  • [35] Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?
    Luescher, Thomas F.
    Mahfoud, Felix
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (26) : 1706 - 1711
  • [36] From SYMPLICITY HTN-3 to the Renal Denervation Global Registry: where do we stand and where should we go?
    Pathak, Atul
    Ewen, Sebastian
    Fajadet, Jean
    Honton, Benjamin
    Mahfoud, Felix
    Marco, Jean
    Schlaich, Markus
    Schmieder, Roland
    Tsioufis, Konstantinos
    Ukena, Christian
    Zeller, Thomas
    [J]. EUROINTERVENTION, 2014, 10 (01) : 21 - 23
  • [37] Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in patients with resistant hypertension to improve patients' adherence
    Kjeldsen, Sverre E.
    Elmula, Fadl Elmula M. Fadl
    Ingrid, O. S.
    Persu, Alexandre
    Jin, Yu
    Staessen, Jan A.
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2015, 1 (01) : 48 - 56
  • [38] REDUCED BLOOD PRESSURE LOWERING EFFECT OF CATHETER-BASED RENAL DENERVATION IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION: DATA FROM POOLED SYMPLICITY HTN TRIALS
    Mahfoud, Felix
    Bakris, George
    Bhatt, Deepak L.
    Esler, Murray
    Kandzari, David
    Kario, Kazuomi
    Krum, Henry
    Mancia, Giuseppe
    Seth, Ashok
    Weber, Michael
    Whitbourn, Robert
    Boehm, Michael
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1527 - A1527
  • [39] Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings
    Esler, Murray
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (08) : 593 - 598
  • [40] PREFERENTIAL REDUCTION IN MORNING/NOCTURNAL HYPERTENSION BY RENAL DENERVATION FOR DRUG-RESISTANT HYPERTENSION: A NEW ABPM ANALYSIS OF SYMPLICITY HTN-3 AND HTN-JAPAN
    Kario, K.
    Bakris, G. L.
    Bhatt, D.
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 : E52 - E52
12345